Table 3 Unadjusted and adjusted Cox regression analyses of the risk factors for each MAC-associated event, MAC-specific mortality, and all-cause mortality.

From: Effect of multidrug therapy on the prognosis of Mycobacterium avium complex pulmonary disease

 

Unadjusted analysis

Adjusted analysis

Hazard ratio (95% CI)

P

Hazard ratio (95% CI)

P

MAC-associated event

 BACES score

1.51 (1.18–1.94)

< 0.01

1.51 (1.18–1.94)

< 0.01

 Multidrug therapy

1.01 (0.55–1.87)

0.97

1.02 (0.55–1.88)

0.96

MAC-specific mortality

 BACES score

2.21 (1.51–3.24)

< 0.001

2.21 (1.51–3.32)

< 0.001

 Multidrug therapy

0.90 (0.37–2.17)

0.82

0.84 (0.33–2.12)

0.71

All-cause mortality

 BACES score

1.88 (1.46–2.42)

< 0.001

1.86 (1.45–2.39)

< 0.001

 Multidrug therapy

0.66 (0.36–1.21)

0.18

0.71 (0.38–1.33)

0.28

  1. BACES body mass index, age, cavitary, erythrocyte sedimentation rate, and sex, CI confidence interval, MAC Mycobacterium avium complex.
Back to article page